Athira Pharma Inc.

0.37
-0.04 (-9.91%)
At close: Mar 03, 2025, 3:59 PM
0.40
7.62%
After-hours: Mar 03, 2025, 06:31 PM EST

Athira Pharma Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Net Income -96.94M -117.67M -95.64M -54.85M -19.95M -5.16M -5.1M
Depreciation & Amortization 455K 969K 845K 479K 251K 2.00 n/a
Stock-Based Compensation 11.05M 10.62M 10.61M 4.62M 633K 253K 196K
Other Working Capital n/a -840K 9.84M 1.01M -9.05M -23K 245K
Other Non-Cash Items -11.73M -1.2M -219K 493K 1.65M 517K 173K
Deferred Income Tax n/a n/a n/a n/a -251K -2 n/a
Change in Working Capital n/a 6.53M 11.94M 6.16M -6.45M 678K 245K
Operating Cash Flow -97.17M -100.75M -72.47M -43.1M -24.11M -3.71M -4.48M
Capital Expenditures -33K -304K -1.14M -1.57M -2.32M n/a n/a
Acquisitions n/a n/a -58.8K 2.51K n/a n/a n/a
Purchase of Investments -14.13M -27.67M -95.29M -299.2M -226.84M -995K -5.25M
Sales Maturities Of Investments 69M 123.06M 154.09M 296.69M 19.05M 2.5M 7.25M
Other Investing Acitivies n/a n/a 58.8K -2.51K 36K 6K 7K
Investing Cash Flow 54.83M 95.09M 57.66M -4.08M -210.07M 1.51M 2.01M
Debt Repayment n/a n/a n/a n/a 1.66M 874K 1.27M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 194K 493K 654K 327K 82.57M 72K 198K
Financial Cash Flow 194K 493K 654K 97.09M 292.75M 946K 1.46M
Net Cash Flow -42.15M -5.17M -14.15M 49.91M 58.57M -1.26M -1.01M
Free Cash Flow -97.2M -101.06M -73.61M -44.67M -26.43M -3.71M -4.48M